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Abstract 
Late diagnosis of HIV results in increased morbidity and mortality and raises the potential for 
onward transmission to others.  It also increases costs to health service providers and impacts 
on national health budgets. This paper reports results from a literature review conducted to 
inform the conduct of an international study investigating barriers to early HIV testing from 
the perspectives of both patients and healthcare professionals. The literature suggests that 
reasons for late presentation include demographic factors such as age, sex and ethnicity; fear 
and stigma associated with an HIV diagnosis; and individual risk appraisal, as well as structural 
and organisational barriers within the healthcare system. Other key issues highlighted by the 
literature review include the fact that: the number of people living with HIV is increasing year 
on year, the proportion of people presenting with a late HIV diagnosis is increasing not only in 
MSMs but also in other less recognised groups such as heterosexual women and in particular, 
older heterosexual men and women. Reasons for late presentation and diagnosis are 
multifactorial, but further research into the issue of late presentation and diagnosis of HIV is 
required, including the exploration of reasons why people continue to present late. The review 
indicated that further work to raise public awareness of the benefits of early testing, together 
with improved education and training for healthcare professionals is vital to improve the uptake 
and timeliness of HIV testing. 
Key words: HIV testing, late presentation, late diagnosis, risk appraisal, barriers, health 
education. 
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Introduction 
Late diagnosis of HIV is detrimental to patients, resulting in increased morbidity and mortality, 
increased risk of onward transmission and higher costs for national health budgets [1]. This 
paper outlines the results of a literature search undertaken to inform the development and 
conduct of the EU INTERREG IVA Channel Programme project, ‘Understanding factors 
behind the late testing and diagnoses of HIV’.  The study, recently completed, elicited both 
patients’ and healthcare professionals’ understanding and experiences of factors determining 
whether to ask for, or recommend an HIV test in Kent and Medway in the UK, and Picardy in 
France. 
In 2012, Public Health England estimated the number of people living with HIV in the United 
Kingdom to be 98,400 [2], of which approximately 20% were unaware of their status. Forty-
seven percent of the 6,360 newly diagnosed people were identified at a late stage (CD4 count 
<350 cells/mm³ within three months of diagnosis). In 2014, the number of new diagnoses had 
risen to 6,509 - the highest figure in both European Union (EU) and European Economic Area 
(EEA) countries [3]. This is almost twice the number of new diagnoses in Italy (3,861), 
Germany (3,525) or Spain (3,366), and whilst the rate of new diagnoses, 10.1 per 100,000 of 
the population is not the worst in either the EU or EEA area, it is still the fifth highest when 
adjusted for reporting delay and adjustment coefficients behind Estonia (22.1/100,000), Latvia 
(17.3/100,000), Luxemburg (14.8/100,000) and Portugal (11.8/100,000), which all have much 
smaller populations [3].  France had 6,372 new diagnoses in 2012 although it did not supply 
data for the later WHO data [4, 5].  
If diagnosed early, HIV patients derive more benefit from the newer, highly active 
antiretroviral therapies [6], so that early diagnosis and treatment can result in a near-normal 
lifespan [2]. Recent increases in the uptake of routine HIV testing within sexual health clinics 
and antenatal care has significantly reduced the proportion of people diagnosed late across all 
exposure groups [2].  Nevertheless, the proportion of late diagnoses in the general population 
remains high, underscoring the need to increase HIV testing in other healthcare settings [2]. 
However; substantial barriers to HIV testing remain at individual, societal, medical and public 
policy levels in the UK and elsewhere [7], and an understanding of such factors is critical to 
the development of effective programmes and treatment strategies [8]. The literature review 
described below was conducted therefore, to inform the development of a mixed methods study 
to elicit barriers to early testing so that specific guidance for clinicians and public health 
providers in both France and the UK could be developed and a public health campaign launched 
to coincide with the national HIV testing week and World AIDS Day at the end of 2014. The 
results of the study, which concluded in 2015 can be seen in a report published by O’Connor 
et al [9].   
Method  
The databases used to source relevant literature included PubMed Central, CINAHL, 
EBSCOhost, SAGE Journals, and Wiley Online Library.  The literature search was conducted 
using the search term ‘HIV’ narrowed with the additional terms: ‘late presentation’, ‘late 
diagnosis’ and ‘late testing’ (Table 1). Fairly broad criteria were developed to ascertain whether 
the papers sourced were suitable for inclusion in the literature review including primary 
research describing healthcare professional or patient/service user viewpoints, literature 
reviews, and a range of national or international opinion papers. These were reviewed to 
identify key themes which would aid the formulation of semi-structured interview schedules 
for healthcare professionals and service users, and a retrospective patient record analysis of 
240 patient records in Kent and Medway as part of the study and an equivalent number in 
Picardy.  
 
Table 1: Results of the literature search  
 
Number of papers retrieved 
PubMed 
Central CINAHL EBSCOhost 
SAGE 
Journals 
Wiley Online 
Library 
Search terms  
HIV + late 
testing 27 9 43 13 4 
HIV + late 
presentation 249 7 195 133 6 
HIV + late 
diagnosis 520 22 271 135 10 
 
Findings 
A small number of papers considered the issue of late testing and diagnosis internationally 
though the majority of primary research papers provided single country perspectives. Four 
opinion papers were reviewed as these were frequently cited by other authors [7, 10, 11, 12], 
and 3 literature reviews were also analysed as these provided both global and European 
perspectives on the issue. Interestingly, primary research papers focused exclusively on patient 
perspectives and none elicited the views of professional health carers. These were mentioned 
in passing in some, although they did not form part of the sample. Most of the quantitative 
studies included large, non-homogenous samples, whereas qualitative studies had smaller 
samples which generally encompassed participants from both high and low-risk populations. 
Tables 2 and 3 provide a broad overview of the papers reviewed.  
Table 2: Literature reviews included in the analysis   
Author 
No of 
papers   
reviewed  
Demographic 
factors 
Risk 
appraisal 
Fear or 
emotional 
responses 
to HIV 
Concerns 
about 
stigma  
Perceived 
treatment 
efficacy 
Specific 
issues for 
migrants 
Structural and 
systemic 
barriers to 
testing 
Adler et 
al (2010) 
63 
articles 
sourced 
22 
countries 
surveyed 
yes no yes no no yes no 
Mukolo 
et al 
(2012) 
36 
articles yes yes yes yes yes no yes 
Savasta 
(2004) 
67 
articles yes yes yes yes no no yes 
Table 3. Summary of research papers reviewed 
  Sample details                                   Themes covered 
Author Country Patients Health 
carers 
Sample 
size 
Demographic 
factors Risk appraisal 
Fear and 
emotional 
responses 
Concerns 
about stigma/ 
stereotyping 
Perceived 
treatment 
efficacy 
Specific issues 
for migrant 
populations 
Structural and 
systemic 
barriers 
Antorini et al (2010) Europe no no no yes no no no no no yes 
Bonjour et al (2008) Venezuela yes no 225 yes yes yes yes no no yes 
Branson et al (2006) USA n/a n/a n/a yes no no no no no yes 
Camoni et al (2013) Italy  yes no 7,300 yes no no no no yes no 
Carrizosa et al (2010) Mexico yes no 362 no no yes yes no no no 
Casau (2005) USA yes no unstated yes no no no no no no 
Castilla et al (2002) Spain yes no 30,788 yes no no no no no no 
Delpierre et al (2007) France yes no unstated no no no no no no yes 
Dowson et al (2012) UK yes no 17 yes yes yes yes no no yes 
Garcia de Olalla et al (2011) Spain  yes no 2,507 yes no no no no yes  
Girardi et al (2007) Global (various) yes no unstated yes yes no no no no yes 
Hanf et al (2011) French Guiana  yes no 398 no yes yes no no yes yes 
Johnson et al (2010)  Europe (various) n/a n/a n/a yes no no no no no yes 
Krentz et al (2004) Canada yes no 241 yes no no no no no  
Lo et al (2011) Taiwan yes no 227 yes yes no yes no no yes 
Pereira et al (2011) Brazil yes no 492 yes no no no no no no 
Schrantz et al (2011) USA n/a n/a n/a no no no no no no yes 
Schwarz et al (2011) USA yes no 41 no yes yes no yes no no 
Sudarshi et al (2008) UK yes no 108 no no no no no no yes 
Sullivan et al (2005) UK and Ireland  yes no 977 yes no no no no no yes 
Vives et al (2012) Spain  yes no 4,651 yes no no no no yes no 
Wohlgemut et al (2012) Scotland yes no 165 yes no no no no no yes 
Yang et al (2010) USA yes no unstated yes no no no no yes no 
Yazdanpanah et al (2010) Europe (various) n/a n/a no yes no yes no no yes yes 
 
The main themes elicited from the literature review regarding the factors behind late testing 
and diagnosis tended to cluster around the following: 
 Demographic factors 
 Individual risk appraisal  
 Fear and emotional responses to a possible diagnosis 
 Concerns about stigma and/or stereotyping 
 Specific issues for migrant populations 
 Structural and systemic barriers to testing 
Demographic factors 
Age was a consistent demographic correlate. Each of the 36 studies reviewed by Mukolo et al 
[8] associated older age with late presentation.  This concurs with primary research data 
showing that older individuals generally do not perceive themselves to be at risk, and 
consequently, are less likely to be tested for HIV than young people [13, 14]. Low socio-
economic status as indicated by employment/occupational status or level of education was also 
widely correlated with late presentation, often overlapping with racial, ethnic and immigration 
status which, together with language barriers or lack of knowledge about the services available 
made it harder for subjects to access testing.  
Although men who have sex with men are at the highest risk for HIV infection overall, they 
are often less likely to present late [11]. Mukolo et al [8] and Adler et al’s [15] literature reviews 
show that males (particularly heterosexual males) are consistently at greater risk of being 
diagnosed late in most countries. This could be due to womens’ higher perception of risk, a 
greater propensity to access health services; or the likelihood that they will be offered HIV 
testing during pregnancy leading to earlier diagnosis as posited by Garcia de Olalla et al. [16]. 
Living in a region with low prevalence of HIV increases the risk of late HIV diagnosis [15]. 
This is certainly true in the UK where the highest rates of late diagnosis may occur outside 
London [9]. Similar patterns have been found in other countries, for example, in France, where 
late presentations may also be higher outside Paris and the Île-de-France area. Suggested 
explanations for this pattern are provided in Adler et al’s literature review [15], which inferred 
that risk is perceived to be lower in areas with low prevalence and where stigma of having a 
test may also be present. A variety of primary studies have identified additional variables 
associated with late HIV testing or delayed diagnosis, including lower levels of educational 
attainment [17, 18], and having previously tested negative for HIV prior to a subsequent 
positive result [18].   
Delpierre et al’s French study [19] found that HIV infection was more common among women 
and in people identified at higher risk of infection, such as men who have sex with men, young 
people and those with multiple sexual partners. Conversely, those who were detected late 
tended to be older, heterosexual males in stable relationships. Other studies in both Italy and 
the US also conclude that older people, non-nationals and heterosexuals are at higher risk of 
being diagnosed late [20, 21]. These populations are not generally included amongst priority 
groups for testing on either side of the Atlantic, even though they may benefit from targeted 
programmes to encourage timely HIV testing when exposed to risk of the virus.  
Risk appraisal 
Denial of risk factors was a common reason for not being tested in studies carried out in the 
UK, French Guiana and a number of European countries [7, 22, 23]. The latter study showed a 
positive correlation between those who had never had an HIV test and their perceptions about 
the perceived efficacy of medical interventions for the illness. Johnson et al’s paper [11] 
pointed out that being a member of a group perceived to be at low risk (i.e. anyone other than 
men who have sex with men or black African) is itself a risk factor for late testing since HIV 
is not at the forefront of the minds of those individuals. Vives et al also recognised barriers 
related to lack of awareness by health professionals about the sexual history of their patients, 
lack of time to assess risk, and to offer or perform the test [24]. The importance of perception 
is also borne out by the studies reviewed by Mukolo et al, which indicate that cognitive 
appraisal of actual or potential risk can influence the timeliness of presentation [8]. It also 
shows that adolescents who considered themselves to be at high risk of infection are more 
likely to seek HIV testing than adults with comparable risk perceptions.   
Fear and emotional responses to HIV 
One study in Mexico found those who ‘preferred not to know’ their status had more than double 
the risk of late testing than those who were prepared to know the results of their test [25]. Fear 
of the consequences of a positive test, including anticipated pain, death, discrimination, feeling 
socially devalued or isolated, and diminished capacity to be economically productive can all 
contribute to late presentation [8, 22, 23]. Fear of HIV as a barrier to testing was also 
highlighted in qualitative service-user interviews conducted for our own study [9].  
Concerns about stigma and stereotyping 
Wohlgemut et al. warn against the danger of healthcare professionals stereotyping ‘at risk’ 
patients since one fifth of diagnoses in their study occurred in those without recognisable 
transmission risks [26].  Fear of disclosure, and subsequent social or legal stigma was a 
common reason for migrants to avoid testing in Yazdanpanah et al’s study [7]. This may be a 
well-founded conclusion however, since Mukolo et al. suggests that decisions about testing are 
often made within social contexts characterised by hostility towards people living with HIV 
and AIDS due to deficits in knowledge about HIV transmission, prevention and treatment; and 
prevailing social norms and values which may stigmatise the individual [8]. Improvements in 
treatment efficacy may result in some de-stigmatisation of HIV/AIDS by rendering it less 
threatening or disabling in key domains of life, although this area is not well researched and 
more evidence is needed, particularly in relation to testing [8].   
Specific issues for migrant populations 
Yazdanpanah et al suggest that specific barriers exist for migrants, including stigmatisation 
within some African communities in the UK [7]. The study showed that many still considered 
HIV to be a deadly disease in these communities which, aligned with the belief that HIV tests 
may not remain confidential would reduce an individual’s chance of gaining permanent 
residence in the UK. Others feared that it would bring them to the attention of immigration 
services, but as an issue it also featured less highly than housing, childcare and employment 
for many of their sub-Saharan respondents.  Language barriers were also found to distort health 
messages, in that migrants may not understand what healthcare services are available or their 
entitlement to them. Adler et al. on the other hand showed that a lack of advocacy for HIV 
infected migrants living in the UK combined with much negative publicity about UK taxpayers 
having to support so-called ‘health tourists’ also increased risk of late presentation [15]. As a 
consequence of these fears, the National Institute for Health and Clinical Excellence (NICE) 
published guidance to promote cultural awareness of these fears among men who have sex with 
men and black African communities in the UK with similar guidance issued at a European level 
[27]. 
Structural and systemic barriers to testing  
In many countries, patient-initiated approaches continue to be the primary model for providing 
HIV testing and counselling.  However, health facilities represent a key point of contact for 
people with HIV who are unaware of their HIV status [7]. Other evidence suggests that many 
opportunities to diagnose and counsel individuals at health facilities are being missed [28, 29]. 
Barriers highlighted in these studies include consent and how this should be gained, the 
necessity for pre-test counselling, logistical barriers such as competing priorities and policy 
objectives, language barriers; and lack of knowledge, education and training for healthcare 
professionals who may be unaware of various factors indicative of HIV infection. These 
include non-typical risk groups such as heterosexual men or women, older people of both sexes; 
and non-specific symptoms which might be indicative of HIV infection including recurrent 
opportunistic infections, malaise, lethargy, anorexia, nausea, myalgia, arthralgia, diarrhoea, 
generalised lymphadenopathy or other health problems [28, 29]. Perceived failure of primary 
care practitioners to address HIV-related topics with their patients can exacerbate the issue of 
late presentation, as can the lack of accessible testing facilities [22]. 
Health policy in the UK has traditionally targeted those at ‘high risk’ of infection, and therefore 
provision and funding is aimed at certain groups. For example, the Terrence Higgins Trust 
(THT) was only funded to offer postal HIV testing kits to African people and gay or bisexual 
men who live in England [30], and the majority of targeted HIV prevention excluded 
heterosexual males, meaning they had less information and fewer opportunities for an early 
test than injecting drug users, MSMs, or women attending antenatal care [8]. Indeed, most 
studies show that injecting drug users have lower rates of late diagnosis than heterosexuals 
[15], and in the UK, these make up only 2% of new diagnoses [2]. 
Discussion:  
Although quite dated, World Health Organisation guidance recommends an ‘opt-out’ approach 
to testing, including the provision of simplified pre-test information, and an increase of HIV 
testing and counselling facilities [31].  In this model, individuals attending a given healthcare 
setting should be offered an HIV test as standard, but can decline. It is clear from evidence that 
this strategy is being put into place. However, many studies still argue for the need to develop 
interventions that increase HIV testing and facilitate earlier entry into care, including routine 
screening in healthcare and non-clinical settings for patients at risk for HIV where this does 
not yet take place [1, 10, 16, 20, 32].  Branson et al’s US study suggests that it might be feasible 
to include HIV testing as a routine part of healthcare practices for all adults and adolescents 
aged 13-64 years, as proposed by the US Centers for Disease Control and Prevention [10].  
Another US study on the implementation of an HIV testing model in an Emergency Department 
showed that it was effective in identifying new patients, notification of results and integrating 
newly diagnosed patients into existing clinical care and procedures [13]. 
A variety of studies looking at healthcare professionals’ perspectives stress the need to increase 
awareness and identify populations which are at risk [24].  These often support the use of mass 
media campaigns in raising awareness and increasing uptake of testing and signposting to 
services, and there is an emerging evidence base for the delivery of targeted HIV prevention 
messages using the internet and social media.  Such technologies potentially offer greater reach 
in certain target populations [33]. Current examples of health promotion interventions along 
these lines include National HIV Testing Week in the UK in the run up to World AIDS Day. 
Other suggestions include improving recognition of HIV symptoms [7], financial incentives, 
and education programmes to motivate healthcare professionals to discuss the need for HIV 
testing with their patients [22, 34].  Pereira et al. suggest that nurses are important carers in this 
regard and could be used to increase the capacity for counselling and educational messages 
targeted at increasing the number of HIV tests [35]. This is in line with Dowson et al’s research 
which suggests that a more proactive approach by healthcare professionals, including general 
practitioners, would increase the frequency of earlier diagnosis [22]. 
Schwarz et al. assert that public health campaigns to increase testing should emphasise the 
effectiveness, tolerability and relative low cost (free for many patients in some health systems) 
and the benefits of early diagnosis [36]. Greater emphasis should be made that anyone engaged 
in unprotected oral, anal or vaginal intercourse should consider their need for testing even 
where ejaculation does not take place. Persons thus tested should be reassured that the results 
of their test will be kept private. In line with the WHO recommendations and research findings 
discussed above, current national guidelines from Public Health England additionally 
recommend that HIV testing should be offered routinely to everyone admitted to hospital and 
people registering with a GP surgery in areas of the country with HIV prevalence greater than 
2 per 1000 people [2]. The guidelines also suggest that the introduction of home testing kits 
would also increase the uptake of early testing. 
Conclusions and recommendations 
The literature reviewed in this paper suggests that many opportunities to identify, counsel and 
test individuals at risk of developing HIV are being missed. Barriers highlighted include over 
complicated consenting processes and pre-test counselling requirements in some countries, 
lack of knowledge or information about transmission risk, concerns about confidentiality or 
inadequate opportunities for testing, as well as logistical barriers such as limited consultation 
times, competing healthcare priorities (such as diabetes or cardiovascular screening), language 
and other cultural barriers. It is necessary however, to increase the rate of HIV testing and 
facilitate speedier entry into the care system for those subsequently diagnosed with HIV.  
Traditional healthcare settings will play a significant role in these developments, but there is 
also need to include non-clinical settings and innovative strategies to reach ‘hard to reach’ 
groups including older heterosexual men and women embarking on new relationships after 
bereavement or divorce, migrants who may be wary of accessing formal healthcare services, 
and social or cultural groups for whom discussion about HIV is still a taboo subject and where 
a positive diagnosis is likely to lead to stigma or exclusion. Much of this work could be led by 
appropriately trained nurses who could also deliver culturally appropriate health education and 
promotion campaigns and point of care testing for MSMs, migrants, and black and minority 
ethnic groups in a wide variety of non-clinical settings. These services should be co-designed 
with the communities themselves, but may include campaigns or awareness raising in 
compulsory, further and higher education settings, pubs, clubs, saunas and other areas where 
sexual interest or activity may be initiated, and churches, community groups or workplaces, 
where more generic information might be provided to reduce the stigma associated with HIV 
testing and encourage people to receive a free and confidential test where they believe 
themselves to have been at risk of HIV transmission. These should include education about the 
increased prevalence of HIV in the general population as well as information about the benefits 
of early testing, improved treatment efficacy, and better health outcomes for those diagnosed 
early. They should also highlight the fact that treatments are far more tolerable and have fewer 
side-effects than earlier medications, and can be obtained at little or indeed no cost in most 
countries.   
Finally, it is important to acknowledge how a lack of sensitivity, awareness or courage on the 
part of healthcare professionals might limit the number of early HIV diagnoses, and the need 
to increase their confidence and competence to offer testing to all those they consider to be at 
risk, as there is evidence that fear of upset or embarrassment still holds many back from making 
such a suggestion. There also needs to be greater willingness to explore sexual risk factors, 
especially in heterosexual males with unexplained symptoms indicative of HIV which continue 
to be missed in many cases, and better awareness of local patterns in HIV transmission, the 
location and availability of testing opportunities for those reluctant to visit a sexual health or 
genitourinary medicine clinic; and an increased willingness to discuss and carry out such tests 
when (for instance), registering a new patient as a means of ‘normalising’ such activity so that 
it becomes the norm rather than the exception in such cases.   
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